We also tested estrogen responsiveness in LAM patient-derived TSC2-deficient 621–101 cells that exhibit constitutively active mTORC1, and in TSC2-expressing 621–103 cells. This evidence concerns the gene TSC2 and lymphangioleiomyomatosis.